Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nossiter, J.
143  Ergebnisse:
Personensuche X
?
1

The National Lung Cancer Audit: The Impact of COVID-19:

Conibear, J. ; Nossiter, J. ; Foster, C....
Clinical Oncology.  34 (2022)  11 - p. 701-707 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Treatment-related toxicity using prostate bed versus prosta..:

Parry, M.G. ; Sujenthiran, A. ; Nossiter, J....
European Urology.  79 (2021)  - p. S1673 , 2021
Link: https://doi.org/10.1016/..
 
?
3

PD-0768 Treatment-related toxicity of prostate bed versus w..:

Parry, M. ; Sujenthiran, A. ; Nossiter, J....
Radiotherapy and Oncology.  161 (2021)  - p. S599 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Determinants of variation in radical local treatment for me..:

Parry, M.G. ; Boyle, J.M. ; Nossiter, J....
European Urology.  79 (2021)  - p. S1698 , 2021
Link: https://doi.org/10.1016/..
 
?
5

PD-0060: Treatment-related toxicity of hypofractionated rad..:

Parry, M. ; Sujenthiran, A. ; Nossiter, J....
Radiotherapy and Oncology.  152 (2020)  - p. S24-S25 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Patient-reported outcomes following a high-dose rate brachy..:

Parry, M.G. ; Nossiter, J. ; Cowling, T.E....
European Urology Open Science.  19 (2020)  - p. e2133 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Comparison of Treatment-Related Toxicity With Hypofractiona..:

Sujenthiran, A. ; Parry, M. ; Nossiter, J....
Clinical Oncology.  32 (2020)  8 - p. 501-508 , 2020
Link: https://doi.org/10.1016/..
 
?
8

PO-1179: Patient-reported outcomes following a highdose rat..:

Parry, M. ; Nossiter, J. ; Cowling, T....
Radiotherapy and Oncology.  152 (2020)  - p. S621 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Patient-reported outcomes after prostate only vs. prostate ..:

Parry, M.G. ; Nossiter, J. ; Cowling, T.E....
European Urology Open Science.  19 (2020)  - p. e2134 , 2020
Link: https://doi.org/10.1016/..
 
?
10

PO-1178: Identifying skeletal-related events for prostate c..:

Parry, M. ; Cowling, T. ; Sujenthiran, A....
Radiotherapy and Oncology.  152 (2020)  - p. S620 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Comparison of complications after transrectal and transperi..:

Berry, B. ; Parry, M. ; Sujenthiran, A....
European Urology Open Science.  19 (2020)  - p. e2311 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Treatment-related toxicity of hypofractionated radiation th..:

Sujenthiran, A. ; Parry, M.G. ; Nossiter, J....
European Urology Open Science.  19 (2020)  - p. e2117 , 2020
Link: https://doi.org/10.1016/..
 
?
13

PD-0057: Patient-reported outcomes after prostate only vs p..:

Parry, M. ; Nossiter, J. ; Cowling, T....
Radiotherapy and Oncology.  152 (2020)  - p. S22-S23 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Trends and variations in risk stratified prostate cancer ma..:

Parry, M.G. ; Cowling, T.E. ; Sujenthiran, A....
European Urology Open Science.  19 (2020)  - p. e1928 , 2020
Link: https://doi.org/10.1016/..
 
?
15

PO-1177: Treatment-related toxicity using prostate only vs ..:

Parry, M. ; Sujenthiran, A. ; Cowling, T....
Radiotherapy and Oncology.  152 (2020)  - p. S620 , 2020
Link: https://doi.org/10.1016/..
 
1-15